JOURNAL OF COORDINATION CHEMISTRY
3
5
3.8 (NCH CH N), 28.7 (CH(CH ) ), 26.7 (CH(CH ) ), 24.1 (CH(CH ) ). HR-MS (ESI): calcd for
2 2 3 2 3 2
3 2
−1
−
+
C H ClN Pd [M − Cl ] 611.2133; found 611.2141. IR (KBr, cm ): 3180, 2951, 2916, 1604,
3
1
42
4
1480, 1419, 1408, 1378, 1326, 1279, 1228, 1134, 1062, 928, 860, 740. Anal. Calcd for [(SIPr)
PdCl (pyrazine)] (C H Cl N Pd): C, 57.46; H, 6.53; N, 8.65%. Found: C, 57.72; H, 6.75; N, 8.38%.
2
31 42
2
4
2
.2.2. [(SIPr)PdCl (pyrimidine)] (1b)
2
1
The procedure yielded 115 mg (89%) of 1b. H NMR (CDCl , 400 MHz) δ (ppm) = 9.24 (s, 1H,
3
pyrimidine-H), 8.76 (d, 1H, J = 4.0 Hz, pyrimidine-H), 8.54 (d, 1H, J = 2.4 Hz, pyrimidine-H),
7
.44–7.40 (m, 2H, Ar–H), 7.32–7.26 (m, 4H, Ar–H), 7.13–7.10 (m, 1H, pyrimidine-H), 4.09 (s, 4H,
NCH CH N), 3.58 (sept, J = 6.8 Hz, 4H, CH(CH ) ), 1.56 (d, J = 6.4 Hz, 12H, CH(CH )2), 1.28 (d,
2
2
3 2
3
1
3
J = 6.8 Hz, 12H, CH(CH ) ). C NMR (CDCl , 100 MHz) δ (ppm) = 184.6 (Ccarbene), 159.9, 157.8,
3
2
3
1
57.6, 147.5, 135.1, 129.5, 124.4, 120.8, 53.8 (NCH CH N), 28.7 (CH(CH ) ), 26.8 (CH(CH ) ),
2 2 3 2 3 2
−
+
24.1 (CH(CH ) ). HR-MS (ESI): calcd for C H ClN Pd [M − Cl ] 611.2133; found 611.2144. IR
3
2
31 42
4
−
1
(
KBr, cm ): 3133, 2966, 2866, 1604, 1462, 1418, 1380, 1350, 1288, 1210, 1162, 1128, 1070,
9
46, 802, 763, 757. Anal. Calcd for [(SIPr)PdCl (pyrimidine)] (C H Cl N Pd): C, 57.46; H, 6.53;
2 31 42 2 4
N, 8.65%. Found: C, 57.68; H, 6.80; N, 8.36%.
2
.2.3. [(SIPr)PdCl (pyridazine)] (1c)
2
1
The procedure yielded 102 mg (79%) of 1c. H NMR (CDCl , 400 MHz) δ (ppm) = 8.87 (d,
3
J = 5.2 Hz, 1H, pyridazine-H), 8.77 (d, J = 4.0 Hz, 1H, pyridazine-H), 7.42–7.38 (m, 2H, Ar–H),
7
4
1
1
.32–7.30 (m, 4H, Ar–H), 7.24–7.21 (m, 1H, pyridazine-H), 7.19–7.16 (m, 1H, pyridazine-H),
.06 (s, 4H, NCH CH N), 3.58 (sept, J = 6.8 Hz, 4H, CH(CH ) ), 1.58 (d, J = 6.8 Hz, 12H, CH(CH ) ),
2
2
3 2
3 2
13
.27 (d, J = 6.8 Hz, 12H, CH(CH ) ). C NMR (CDCl , 100 MHz) δ (ppm) = 185.9 (Ccarbene), 153.9,
3
2
3
51.5, 147.5, 135.3, 129.3, 128.6, 127.7, 124.3, 53.8 (NCH CH N), 28.7 (CH(CH ) ), 26.7
2
2
3 2
−
+
(CH(CH ) ), 24.1 (CH(CH ) ). HR-MS (ESI): calcd for C H ClN Pd [M − Cl ] 611.2133; found
3 2 3 2 31 42 4
−1
6
1
8
11.2132. IR (KBr, cm ): 3145, 3106, 3090, 2960, 1606, 1482, 1470, 1380, 1330, 1230, 1188,
054, 849, 740. Anal. Calcd for [(SIPr)PdCl (pyridazine)] (C H Cl N Pd): C, 57.46; H, 6.53; N,
.65%. Found: C, 57.28; H, 6.35; N, 8.83%.
2
31 42
2
4
2
.3. Preparation of dinuclear NHC–Pd compounds (2a and 2b)
Procedure 1: [Pd(μ-Cl)(Cl)(SIPr)] (0.10 mmol, 113.6 mg) and diazine (0.10 mmol, 8.0 mg) were
2
stirred in CH Cl (5.0 mL) at ambient temperature for 6 h to give a yellow solution. The solvent
2
2
was reduced and the resulting residue was washed with diethyl ether to give the dinuclear
NHC-Pd complexes.
Procedure 2: A mixture of 1a or 1b (0.10 mmol, 64.8 mg) and [Pd(μ-Cl)(Cl)(SIPr)]2
(
0.05 mmol, 56.8 mg) was stirred in CH Cl (5.0 mL) at ambient temperature for 3 h. The
2 2
solvent was reduced and the resulting residue was washed with ether to give dinuclear
NHC–Pd complexes 2a and 2b.
2
.3.1. [(SIPr)PdCl ] (μ-pyrazine) (2a)
2 2
1
The procedure yielded 98 mg (81%) of 2a. H NMR (CDCl , 400 MHz) δ (ppm) = 8.52 (br, 4H,
3
pyrazine-H), 7.29 (br, 4H, Ar–H), 7.27 (br, 8H, Ar–H), 4.07 (s, 8H, NCH CH N), 3.50 (sept,
2
2
J = 6.8 Hz, 8H, CH(CH ) ), 1.48 (d, J = 6.8 Hz, 12H, CH(CH ) ), 1.25 (d, J = 6.8 Hz, 12H, CH(CH ) ).
3
2
3 2
3 2
13
C NMR (CDCl , 100 MHz) δ (ppm) = 183.9 (Ccarbene), 147.4, 145.9, 134.9, 129.5, 124.3, 53.8
3
(
NCH CH N), 28.6 (CH(CH ) ), 26.7 (CH(CH ) ), 24.1 (CH(CH ) ). HR-MS (ESI): calcd for
2 2 3 2 3 2 3 2